| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 3e-05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.23 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 0.0004 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.21 | 0.001 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |